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INTRODUCTION
The fetus differs from the adult in that it increases blood
flow to different organs during growth by adjusting the dis-
tribution of its cardiac output (1). During generalized fetal
asphyxia, there is a significant redistribution of blood flow
away from non-essential organs to maintain flow to the brain,
the heart and the adrenals. This is thought to occur as a result
of a altered response to sympathetic alpha receptors (2). Ani-
mal experimental data have shown that in the presence of
hypoxia, there is a reduction in blood flow to visceral organs,
muscle and skin while preserving flow to the heart, the brain,
and the adrenals and away from non-essential organs such as
the carcass, the skin and limbs (2, 3). The exact mechanism
is not fully understood. Blood flow could be redistributed as
a result of a selectively increased sensitivity of different vascu-
lar beds to vasoconstrictive agents, or a decrease response to
vasodilatory agents. The aims of this study were: 1) to deter-
mine if maternal oxygen modification using a maternal tra-
cheal infusion of nitrogen could be carried out safely for a five
day period, 2) to determine the effect of mild hypoxemia on
fetal and maternal pH, blood gases, and hematocrit, as well
as fetal glucose, and lactate, 3) to determine if mild hypoxia
alters the responsiveness to vasoconstrictive agents in the renal
and the femoral arteries of the fetal sheep, and 4) to determine
if this response is affected by the nitric oxide (NO) synthase
inhibitor (N-nitro-L-arginine methyl ester, L-NAME).
MATERIALS AND METHODS
Animal preparation
All the procedures for housing, handling, surgical implan-
tation of catheters, and postoperative management were app-
roved by Wake Forest University’s Institutional Care and Use
Committee. Ten pregnant sheep (average weight 60 kg) were
operated at 116 to 124 days’ gestation (term, 145 days) under
0.75% halothane general anesthesia. Polyvinyl catheters were
placed in the maternal carotid artery, jugular vein, and trachea.
The tracheal catheter (3.5 mm outer diameter and 2.5 mm
inner diameter) was introduced in the direction of the lungs
to a distance of 15 cm into the trachea from a point approx-
imately 2 to 3 cm below the cricoid (4). Polyvinyl catheters
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Chronic Hypoxia Alters Vasoconstrictive Responses of Femoral Artery
in the Fetal Sheep
The purpose of this study was to determine if mild hypoxia alters the responsiveness
to vasoactive agents in the renal and the femoral arteries in the fetal sheep. Ten preg-
nant sheep were operated under halothane anesthesia at 116 to 124 days’ gesta-
tion. A maternal tracheal catheter was placed for infusing compressed air (control
group, n=5) or nitrogen (hypoxia group, n=5) starting on post operative day 6 and
maintained for 5 days. Femoral and renal arteries were harvested from the fetus to
study the constriction response to phenylephrine (PE 10
-9 to 10
-5 mol/L). To deter-
mine the involvement of nitric oxide as a modulator of vessel constriction, N-nitro-L-
arginine methyl ester (L-NAME) was used at a concentration of 10
-4 mol/L in parallel
chambers. In the hypoxia group, maternal Pao2 significantly decreased from a base-
line of 110.4±1.4 to 80.5±1.6 (mmHg, p<0.01), fetal Pao2 significantly decreased
from a baseline of 20.9±0.3 to 15.5±0.1 (mmHg, p<0.01). Hypoxia was associ-
ated with a significant increase in PE maximal response in the absence (184.5±6.6
vs. 146.2±4.3) and presence (166.9±6.3 vs. 145.0±4.5) of L-NAME, and a de-
crease in EC50 in the absence (6.0±1.1 vs. 27.0±4.1) of L-NAME of femoral arteries.
However, there were no significant differences in PE maximal response and EC50
in the absence and presence of L-NAME of renal arteries. We concluded that mild
chronic hypoxia seems to increase the fetal femoral artery response to PE, but not
in the fetal renal artery. This observation is consistent with a redistribution of cardiac
output away from the carcass. 
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were introduced into the fetal carotid artery, jugular vein, and
amniotic cavity as previously described (5). All catheters were
exteriorized through the flank of the ewe. All the animals
received ampicillin (1 g intravenously) and gentamicin (80
mg intravenously) once postoperatively and were allowed to
recover for 5 days.
Experimental protocol
The experimental protocol began on the sixth day after
surgery and continued for a period of 5 days. On the day before
the experiment (day 0), no gas was infused into the maternal
trachea. On the first experimental day (day 1), either com-
pressed air (control, n=5) infused at a rate of 4.5 L/min or
nitrogen (hypoxia, n=5) were infused through the tracheal
catheter. Nitrogen flow was titrated (3-6 L/min) in order to
achieve a 25% drop in the fetal Pao2 without causing fetal aci-
dosis. Maternal hypocarbia due to hyperventilation was avoid-
ed by the simultaneous infusion of CO2 at a rate of 0.25-0.5
L/min to the tracheal catheter. Blood samples were obtained at
30-min intervals for 3 hr and at 6 hr after initiation of nitro-
gen gas infusion. Blood gases were measured in the morning
and evening on each subsequent day. Throughout the exper-
iment, fetal and maternal heart rate, fetal and maternal blood
pressure, and amniotic cavity pressure were continuously moni-
tored. Heparinized arterial blood samples (1 mL) were obtain-
ed for measurement of pH, blood gases, and hematocrit. Addi-
tional venous samples (1.5 mL) were obtained for measure-
ment of plasma glucose and lactate. The blood gases were
measured by means of a Radiometer (Copenhagen ABL5TM,
Skanderborg, Denmark) maintained at a temperature of 39℃.
Hematocrit was measured by an Adams Readacrit micro-he-
matocrit centrifuge (Clay Adams, Inc., Chatsworth, Califor-
nia, U.S.A.). Plasma glucose and lactate were measured by
specific enzymatic spectrophotometric method using glucose
and lactate reagent (Sigma Diagnostics, St. Louis, Missouri,
U.S.A.).
Tissue collection
On experimental day 6, the fetuses were removed by cesare-
an section under halothane anesthesia and the ewe euthanized.
The fetal sheep were sacrificed by injecting a lethal dose of
pentobarbital sodium (50 mg) into the umbilical vein. Fetal
renal and femoral arteries were collected, placed in ice-cold
saline solution (4℃) and carefully dissected free of visible
adventitia.
Arterial ring preparation
The femoral artery and the first branch of the renal artery
proximal to the first bifurcation were cut into rings of 3 mm
long and suspended by use of two stainless steel wires that
were carefully inserted in the lumen of the ring. Each ring
was mounted in 20 mL organ chambers (Radnoti, Monrovia,
CA, U.S.A.) filled with modified Krebs-Henseleit solution com-
posed of (mM) 118 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4,
25.0 NaHCO3, 2.5 CaCl2, and 11.1 glucose, containing 10-5
mol/L indomethacin warmed at 37℃ and gassed with 95%
oxygen and 5% carbon dioxide. In our experiments, we used
indomethacin in the arterial ring to eliminate any contribu-
tion of locally produced prostaglandins. Isometric tension was
measured continuously with a force transducer and recorded on
a Grass Instrument Co. (Quincy, Massachusetts, U.S.A.) No.7
polygraph. Before the start of the experiment each chamber
was washed three times and the rings were allowed to equi-
librate for at least 60 min. The rings were stretched to their
optimum length-tension relationship by repeated stimulation
with potassium chloride (40 mM/L) over a 1-hr period. To
study the constriction response, the vessel was progressively
constricted using phenylephrine (PE 10-9 to 10-5 mol/L). To
determine the involvement of nitric oxide as a modulator of
vessel constriction, L-NAME was used at a concentration of
10-4 mol/L in parallel chambers. The femoral and renal arteries
from the same animals were studied concurrently. Each ves-
sels had a recorded response to KCl (KClmax) which was used
to index the maximum response to PE. The percent maximal
response to each dose of PE and the EC50 (the PE dose yielding
50% of the maximum contraction) were calculated from com-
puter generated log curves. EC50 values were derived from
nonlinear least square regression analysis. Vessels were ana-
lyzed and grouped by normoxic or hypoxic conditions, and
the presence or absence of L-NAME.
Statistical analysis
Data are presented as mean±SEM throughout the article.
Comparisons over the entire experimental time were performed
by using repeated-measures analysis of variance and the Stu-
dent-Newman-Keuls methods. The response to PE is express-
ed as the percent of the KCl-induced maximum constriction.
EC50 was derived from the ‘‘linear portion of the sigmoidal
response curve’’ using Sigma Plot Scientific Graph System
(Jandel Scientific, San Rafael, California, U.S.A.). Comparisons
between hypoxia and control groups for all variables in vas-
cular response were performed by using a paired t test. A p
value of <.05 was considered statistically significant.
RESULTS
Maternal blood gases, pH, and hematocrit
As shown in Table 1 there was no significant difference in
maternal baseline Pao2 between the ‘‘control’’ group and the
‘‘hypoxic’’ group (111.4±1.8 vs. 110±1.4 mmHg respec-
tively). Maternal Pao2 in the group receiving the continuous
nitrogen infusion significantly decreased from a baseline valueChronic Hypoxia Alters Vasoconstriction Responses 15
of 110±1.4 to a value of 81.4±4.4 mmHg at day 3 (p<
0.01) and 76.0±3.9 mmHg at day 5 (p<0.01).
Maternal Paco2 in the two groups was not different at base-
line (36.5±0.8 vs. 35.7±0.6 mmHg) or during the study
(Table 1). Similarly, maternal pH was not significantly dif-
ferent at baseline between the two groups (7.47±0.01 vs.
7.47±0.01), at day 3 (7.46±0.02 vs. 7.47±0.02) or at
day 5 (7.44±0.01 vs. 7.47±0.01) control versus hypoxia
respectively.
No differences in maternal hematocrit between the two
groups were observed at baseline (27.0±3.1 vs. 27.4±2.1%)
or during the study period (Table 1).
Maternal plasma glucose and plasma lactate
Maternal plasma glucose levels were not different during
the study period between groups at baseline (59.0±7.1 vs.
47.2±3.8 mg/dL). During the experimental period mater-
nal plasma glucose levels were not different at day 3 (59.8±
3.4 vs. 54.9±3.5 mg/dL) or at day 5 (60.7±4.6 vs. 56.4±
3.5 mg/dL). In either the controls or the hypoxic group mater-
nal plasma glucose levels did not change significantly. Mater-
nal plasma lactate levels were not different between the two
groups at baseline (6.12±0.10 vs. 4.63±0.85 mg/dL) or
during the study (Table 1).
Fetal blood gases, pH and hematocrit
Fetal Pao2, Paco2, pH, and hematocrit were not significantly
affected during the experimental period in control group. At
baseline there was no difference in either the Pao2, Paco2, pH,
or hematocrit between the controls and the hypoxic group. In
the hypoxic group, values for fetal Pao2 at day 3 (15.4±0.5
mmHg) and day 5 (15.5±0.4 mmHg) were significantly lower
than fetal Pao2 obtained at baseline for that group (20.9±0.3
mmHg; p<0.01). Fetal Paco2, pH, and hematocrit were not
Day 0
CH
Day 1
CH
Day 2
CH
Day 3
CH
Day 4
CH
Day 5
CH
Day of necropsy
CH
Pao2, mmHg 111.4± 110.4± 112.1± 80.1± 111.5± 83.4± 116.3± 81.4± 115.9± 83.0± 116.2± 76.0± 114.6± 80.5±
1.8 1.4 3.5 3.1* 3.2 3.3* 3.0 4.4* 3.8 3.7* 4.4 3.9* 1.5 1.6*
Paco2, mmHg 36.5± 35.7± 37.9± 35.7± 37.6± 35.5± 36.5± 35.6± 36.1± 34.8± 37.3± 35.2± 37.0± 35.4±
0.8 0.6 1.5 0.9 1.4 0.8 1.4 0.9 0.7 0.7 1.0 0.6 0.5 0.2
pH 7.47± 7.47± 7.46± 7.47± 7.46± 7.48± 7.46± 7.47± 7.45± 7.47± 7.44± 7.47± 7.45± 7.47±
0.01 0.01 0.02 0.01 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.01 0.01 0.01
Hct, % 27.0± 27.4± 27.0± 27.8± 26.5± 28.8± 26.3± 27.6± 25.7± 27.9± 25.5± 28.1± 26.3± 28.2±
3.1 2.1 2.5 2.0 2.6 1.8 2.7 1.8 3.2 2.2 3.0 1.9 1.0 0.8
Lactate, mg/dL 6.12± 4.63± 4.66± 6.85± 5.50± 5.75± 5.09± 6.30±
0.10 0.85 0.59 0.89 0.85 0.41 1.09 0.50
Glucose, mg/dL 59.0± 47.2± 59.8± 54.9± 60.7± 56.4± 60.3± 55.6±
7.1 3.8 3.4 3.5 4.6 3.5 2.8 2.4
Table 1. Maternal arterial blood gases, hematocrit, and metabolites in control and hypoxic fetal sheep
Values are mean±SE. C, Control; H, Hypoxic group; Hct, Hematocrit.
*p<0.05 repeated-measures analysis of variance and Student-Neuman-Keuls test.
Pao2, mmHg 19.8± 20.9± 20.0± 15.5± 20.5± 15.6± 19.1± 15.4± 19.0± 15.7± 19.1± 15.5± 19.6± 15.5±
0.7 0.3 0.5 0.2* 0.5 0.3* 0.4 0.5* 1.0 0.3* 0.3 0.4* 0.2 0.1*
Paco2, mmHg 50.1± 48.5± 50.8± 48.0± 50.8± 48.2± 50.9± 47.1± 51.2± 48.2± 51.1± 49.5± 50.9± 48.2±
1.0 0.5 1.4 0.7 1.2 0.6 1.1 0.8 1.1 0.8 1.0 0.6 0.5 0.3
pH 7.34± 7.36± 7.34± 7.36± 7.35± 7.36± 7.34± 7.39± 7.35± 7.36± 7.34± 7.35± 7.34± 7.36±
0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00
Hct, % 31.5± 34.6± 30.0± 34.0± 30.0± 34.2± 30.5± 35.2± 30.0± 34.4± 30.8± 35.1± 30.3± 34.7±
2.8 0.6 2.5 0.5 2.1 0.8 1.8 1.0 0.6 1.5 2.1 2.1 0.6 0.5
Lactate, mg/dL 14.5± 13.0± 14.2± 22.6± 18.2± 28.8± 16.2± 25.7±
0.7 0.8 1.2 2.6* 0.9 2.8* 0.9 2.0*
Glucose, mg/dL 14.3± 14.2± 16.9± 18.7± 16.1± 16.2± 16.9± 17.4±
2.9 0.8 2.2 1.7 2.2 1.3 1.5 1.1
Table 2. Fetal arterial blood gases, hematocrit, and metabolites in the control and hypoxic groups
Values are mean±SE. C, Control; H, Hypoxic group; Hct, Hematocrit.
*p<0.05 repeated-measures analysis of variance and Student-Neuman-Keuls test.
Day 0
CH
Day 1
CH
Day 2
CH
Day 3
CH
Day 4
CH
Day 5
CH
Day of necropsy
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significantly different at day 3 and at day 5 from baseline dur-
ing maternal infusion of nitrogen (Table 2).
Fetal plasma glucose and plasma lactate
There were no significant differences in the fetal plasma
glucose and lactate levels between the control and the hypoxic
groups at baseline (Day 0). In the control group, plasma glu-
cose and lactate levels did not significantly change on day 3
or day 5. In the hypoxic group, fetal plasma lactate levels rose
significantly from 13.0±0.7 at baseline to 22.6±2.6 (mg/
dL; p<0.01) on day 3 and continued to increase at day 5 (28.8
*p<0.01.
Artery L-NAME
Maximal response
Control
(n=5)
Hypoxia
(n=5)
EC50 (×10
-8 M)
Control
(n=5)
Hypoxia
(n=5)
Renal Without 110.9±2.5 119.7±2.5 29.1±3.1 35.5±3.0
Femoral Without 146.2±4.3 184.5±6.6* 29.8±3.9 34.4±4.7
Table 3. Responsiveness of isolated fetal sheep renal and femoral
arteries to phenylephrine.  Arteries were studied with and without
L-NAME 10
-4 M in the bath. Contractile response is expressed as
percentage of KCl maximal response for each individual vessel
*p<0.05; 
� p<0.01.
Artery L-NAME
Maximal response
Control
(n=5)
Hypoxia
(n=5)
EC50 (×10
-8 M)
Control
(n=5)
Hypoxia
(n=5)
Renal With 134.5±3.7 133.4±7.3 14.9±3.3 7.5±1.8
Femoral With 145.0±4.5 166.9±6.3* 27.0±4.1 6.0±1.1
�
Table 4. esponsiveness of isolated fetal sheep renal and femoral
arteries to phenylephrine. Arteries were studied with and without
L-NAME 10
-4 M in the bath. Contractile response is expressed as
percentage of KCl maximal response for each individual vessel
T
e
n
s
i
o
n
 
(
%
)
220
200
180
160
140
120
100
80
60
40
20
0
1e-9 1e-8 1e-7 1e-6 1e-5
Phenylephrine Dose (M)
Renal
Fig. 1. Concentration-effect curves for phenylephrine (PE 10
-9 to 10
-5 mol/L) in isolated fetal sheep renal and femoral arteries obtained from
normoxic (control group n=5) and hypoxic fetuses (hypoxia group n=5). Arteries were studied with and without L-NAME in the bath. Results
are expressed as a percentage of the maximal response to KCl in each vessel and presented as mean±SEM.
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Hypoxia±2.8 mg/dL; p<0.01). Fetal plasma glucose levels did not
significantly change on day 3 or day 5 in the hypoxic group
(Table 2).
Effects of hypoxia on fetal renal and femoral artery constric-
tion by phenylephrine
There was a significant increase in the femoral artery max-
imal response to PE in the absence (184.5±6.6 vs. 146.2±
4.3) and presence (166.9±6.3 vs. 145.0±4.5) of L-NAME
in the hypoxic group (Table 3, 4). As shown in Fig. 1, this
difference was evident whether or not the vessel had been pre-
treated with the NOS inhibitor, L-NAME. However, there
were no significant differences in PE maximal responses of
renal arteries between the control and hypoxia groups in the
presence or absence of L-NAME. A significant left-shift in
the femoral artery dose response relationship to PE was also
observed in the hypoxic group when pretreated with L-NAME
in Fig. 1. As shown in Table 4, the PE EC50 in the hypoxic
group was significantly lower than that of the control group
in the presence of L-NAME (6.0±1.1 vs. 27.0±4.1×10-8
M; p<0.01). There were no significant differences of PE EC50
in renal and femoral arteries in the absence of L-NAME bet-
ween control and hypoxia group (Table 3).
DISCUSSION
We found that five days of mild fetal hypoxemia using
maternal tracheal administration of nitrogen is well tolerat-
ed by the mother and the fetus. At the onset of the nitrogen
infusion, we observed a mild decrease in maternal Paco2 as the
mother hyperventilated in response to the fall in Pao2. This
decrease was easily adjusted by adding CO2 to the nitrogen
infusion, and values were not different than those seen at base-
line. In this protocol, we aimed to decrease fetal Pao2 by 25%
which achieved and was well tolerated by the mother. Towell
et al. (6) investigated the response to a decrease in fetal arte-
rial Pao2 of 5 mmHg or less sustained for a period of 24 hr in
the chronically instrumented fetal lamb. They showed that
the fetal lamb at 122 to 139 days’ gestation was highly sen-
sitive to small decrements in Pao2 of 5 mmHg or less. Fetal
hypoxemia was not associated with any change in fetal pH.
During exposures to hypoxemia, fetal plasma lactate and cor-
tisol were increased above preliminary values. The normal
range of blood gases and acid-base balance in fetal sheep of
120-126 days’ gestation were Pao2 21.4±0.9 mmHg, Pco2
46.0±0.9 mmHg, pH 7.36±0.01 (7). We found that mild
hypoxia did not significantly affect maternal and fetal pH,
nor did it affect fetal Paco2. There was no significant change
in fetal glucose plasma concentration during the entire exper-
iment. Plasma lactate levels progressively increased in the
hypoxic fetuses from baseline to a maximum on day 5. This
finding is consistent with that of Towell et al. (6). Thus, despite
the absence of significant changes in fetal pH and Paco2, the
fetus had a reduction in oxygen availability sufficient to cause
anaerobic metabolism and lactate production. Maternal lac-
tate plasma levels were not significantly increased in the con-
trols or the hypoxic animals suggesting that the elevation in
fetal plasma lactate levels was not due to transport of mater-
nal lactate across the placenta. We cannot eliminate the pos-
sibility that placental lactate production was increased and
thus contributed to the observed increase in fetal lactate levels.
We found that this simple method has the major advantage
of causing mild fetal hypoxia while the mother is eating and
drinking freely without obvious discomfort during the entire
course of nitrogen infusion. Selected specimens of maternal
trachea were examined at the time of necropsy. There were
only minimal areas of inflammation at the site of the catheter
into the trachea and no signs of granulation tissue or obvious
infection were noted. We consider that the tracheal nitrogen
administration is a simple experimental tool to cause mild
fetal hypoxia that can potentially be carried out for much
longer study periods. We suggest that this model could be
helpful to study the effect of long term mild hypoxemia on
the cardiovascular system in studies related to fetal program-
ming. Fetal programming is an area of great interest and this
model of prolonged mild hypoxemia may well serve as a model
to study the growth impaired fetus during infancy and dur-
ing adult life.
Pregnancies that are complicated with chronic hypoxia are
associated with several perinatal problems including fetal
growth restriction and increased mortality and morbidity (8-
10). The growth restriction is asymmetric with brain and
heart weight being reduced less than other organs. This asym-
metry has been ascribed to redistribution of fetal cardiac out-
put during hypoxia favoring the brain and heart. Redistribu-
tion of blood flow may occur as a result of altered response to
sympathetic alpha receptors (2). We found that mild hypoxia
increased the sensitivity to PE in the femoral artery but not
in the renal artery. This increase in contractile response seemed
to be part due to alteration in NO production as the presence
of the nitric oxide synthase inhibitor L-NAME did signifi-
cantly affect the response to PE under basal and hypoxic con-
dition. The contractile response to PE when L-NAME was
added to the bath would suggest that NO production and
or release may be involved in the fetal femoral arteries. The
effect of hypoxia on the expression of the endothelial cell iso-
form of NOS (eNOS) has been evaluated in cultured endothe-
lial cells. The results of these studies are however conflictive.
In endothelial cells from human umbilical vein, hypoxic incu-
bation inhibits eNOS expression (11) whereas it is associated
with increase in both eNOS protein and mRNA (12) in endo-
thelial cells from bovine aorta. Vascular reactivity to the sodi-
um nitroprusside was increased by lowering Pao2 in the tis-
sue bath. Sensitivity also increased after endothelium denuda-
tion and L-NAME treatment, suggesting that endothelium-
derived nitric oxide inhibits nitrovasodilator relaxation in
Chronic Hypoxia Alters Vasoconstriction Responses 17isolated rat aortas (13). In fetal guinea pigs, acute hypoxia
inhibited endothelium-dependent relaxation in response to
acetylcholine and A23187, and increased sensitivity to sodi-
um nitroprusside. Chronic hypoxia inhibited maximal relax-
ation of arteries in response to acetylcholine but not relaxation
of arteries in response to sodium nitroprusside with respect
to relaxation seen in arteries from normoxic fetuses. They con-
cluded that hypoxia may alter relaxation of fetal arteries by
decreasing the availability of oxygen for nitric oxide produc-
tion and causing vascular adaptations related to altered nitric
oxide release (14). 
The present results are consistent with the result found by
Millard et al. (15) in the fetal lamb during acute hypoxia. In
that experiment, acute fetal hypoxia was induced by admin-
istering a mixture of 10% oxygen in nitrogen to the mother
for 10 min. They showed that during hypoxia, there was an
immediate vasoconstriction of the iliac vessels whereas the
renal bed did not constrict initially, and in some experiments,
the renal bed actually dilated in response to acute hypoxia.
After blockade of prostaglandin synthesis, the renal vascular
bed behaved like the iliac bed, showing an immediate and
marked vasoconstriction. Even under this protocol, 5 days
of mild fetal hypoxia without hypocarbia and alkalosis, did
not alter the responsiveness of these renal vessels to PE. It is
possible that greater degree of hypoxia could change the res-
ponsiveness of these vessels to vasoconstrictive agents such as
PE. Other factors, such as endothelial-derived hyperpolariz-
ing factors or endothelin-1 which we have not tested could
potentially be involved and affect one particular vessel more
than the others. Exposure to normobaric hypoxia has previ-
ously been shown to increase levels of the endogenous vaso-
constrictor endothelin in plasma and aorta of Sprague-Daw-
ley rats (16).
In the present study, the increased contractile response to
PE by the femoral artery in the hypoxic fetuses is different
from what has been reported in nonpregnant rats exposed to
chronic hypoxia (17). Studies of the effects of chronic hypoxia
on in vivo systemic vasoreactivity have yielded conflicting
data. Aoki and Robinson (18) found augmented pressor res-
ponses to adrenoreceptor agonists in the hindlimb of chron-
ically hypoxic rats. In contrast, Jin et al. (19) have demonstrat-
ed impaired responses to vasopressin infusion in hypoxia-adapt-
ed rats. Fukuda et al. (20) have reported that changes in sys-
temic vascular resistance during infusion of phenylephrine
and angiotensin II were not different in chronically hypoxic
guinea pigs and normoxic controls. In these two studies chro-
nic hypoxia decreased the contractile sensitivity to PE by do-
wnregulating  1-adrenergic-receptors number and by alter-
ing the excitation-contractile coupling in vascular smooth
muscle (21). This difference may be due to the fact that these
studies were done in adults and that these particular vascular
beds were not studied. 
In conclusions, five days of continuous maternal tracheal
nitrogen infusion can induce fetal mild hypoxia without fetal
acidosis. Mild chronic hypoxia seems to increase vasoconstric-
tive responses of femoral arteries in the fetal sheep. In addition,
L-NAME pretreatment significantlly decreased EC50, along
with the increased maximal contraction response. Therefore,
the increase in contractile response may at least in part be due
to alteration in NO production. Further studies are needed
to confirm the effects of mild chronic hypoxia on renal and
femoral vessel reactivity in the fetal sheep.
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